Print

Print


Re-implanted stem cells tackle Parkinson's
16:35 08 April 02

NewScientist.com news service

A man with Parkinson's disease whose own neural stem cells
were extracted from his brain, grown in the lab, and re-implanted
a few months later has shown improvement in his symptoms
a year after the transplant, a team of neurosurgeons announced
on Monday.

The significance of the experiment is still unclear, since only one
patient has undergone the procedure and a longer follow-up must
be done to assess the real benefits.

But if additional transplants confirm the improvement seen in the
first patient, the technique might rival, and possibly outshine,
other cell-based therapies under investigation.

Doctors have long searched for cells to replace the neurons
damaged in Parkinson's disease. One option is to use neural cells
taken from aborted fetuses, which seem to improve the disease in
some patients but have been linked to serious adverse events
in clinical trials (New England Journal of Medicine vol 344, p 710).

Researchers are also testing cancer cells that can be coaxed
to become neurons and there is even the possibility of using
pig neurons, though they carry risks of immune rejection and
transmission of unwanted viruses.

Rapid progression
Yet the best scenario of all, to use a patient's own neural stem
cells to make functional neurons which can be implanted back
into their brains, has remained an unattainable goal until now.

But Michel Levesque, a neurosurgeon at Cedars-Sinai Medical
Center in California and vice president at Celmed BioSciences
in Canada, says his team has made that scenario work in one
patient. He talked about the transplant at the Annual Meeting
of the American Association of Neurological Surgeons
in Chicago.

The man, 57, had rapidly progressing symptoms despite treatment
with drugs. Neural stem cells were extracted from his brain and
the cells were grown in the laboratory for several months under
conditions that favoured the development of dopaminergic
neurons, the neurons that degenerate in Parkinson's disease.
The new cells were then implanted into his brain, and the man
was monitored over the course of a year.

"After six months of the transplantation, we observed
a progressive regression of the motor deficits," says Levesque.
A year later, the man's condition continued to improve, he says.

Early days
But patient's hopes should not be raised too high yet.
Neurologist Arnold Kriegstein of Columbia University says
more studies need to be done to really prove that the technique
works.

"This is an anecdotal report, no control has been done,"
he says.

A one year follow-up is too early to tell whether there will be
any adverse effects, he says, and it is important to make sure
the neurons are truly the dopaminergic kind, since other types
of neurons could be very harmful if transplanted: "They could
create seizures."

Sylvia Pagán Westphal, Boston

SOURCE: New Scientist
http://www.newscientist.com/news/news.jsp?id=ns99992139

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn